Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
1.703
-0.397 (-18.91%)
Nov 16, 2026, 3:30 PM EST - Market open

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $2.87M in the quarter ending September 30, 2026, with 287.18% growth. This brings the company's total for the last twelve months to $33.65M, up 1,171.58% year-over-year. In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%. That makes Aligos Therapeutics the 30,665th largest company in the world by revenue and 4,043rd in the United States.

Revenue (ttm)
$33.65M
Revenue Growth
+1,171.58%
P/S Ratio
0.31
Revenue / Employee
$410,317
Employees
82
Market Cap
10.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.19M-1.76M-44.59%
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.